DeLauro Renews Push To Give FDA Mandatory Recall Authority For Drugs
Executive Summary
"FDA’s failure to stop companies from selling ranitidine makes the United States government complicit in exposing infants and adults to the risk of cancer," says Rep. DeLauro in letter to FDA and HHS. She also re-introduced legislation proposing FDA have mandatory recall authority for drugs.
You may also be interested in...
DeLauro and Durbin's Latest Food Safety Agency Legislation Would Carve Out FDA Pieces Only
In their fifth attempt, Rep. DeLauro an Sen. Durbin are trying something new to create an independent food safety agency by splitting off food safety departments from the FDA.
House Appropriators Say Infant Formula Shortage Signals Restructuring Needed At US FDA
"Many of the problems facing [the FDA] can be solved through strong leadership rather than more money,” says Rep. Andy Harris during Appropriations subcommittee hearing, Committee Chairwoman Rosa DeLauro continues her criticism of FDA's regulation of industries under its oversight, saying a "structural problem" caused infant formula shortage.
DeLauro Whistles For Investigation Of US FDA Response To Whistleblower Report On Abbott Formula Facility
Appropriations chairwoman Rosa DeLauro wants answers from HHS Office of Inspector General about FDA’s response to whistleblower report of contamination at Abbott Nutrition infant formula facility. Report described pattern of unsatisfactory quality control practices at the plant.